What’s being presented at the AUA in May: Part VI

There are five sessions on prostate cancer detection and screening at the annual meeting of the American Urological Association (AUA) this year that include 92 presentations and posters. For each session we have tried to identify at least one of the more interesting posters from the data to be presented. … READ MORE …

How to mislead the public: a case study in apparent naivety

An article in today’s Daily Telegraph in the UK starts with the misleading statement that, “Up to half of men diagnosed with prostate cancer are being given ‘false hope’ by tests that are underestimating the severity of their disease, according to the authors of a new study.” … READ MORE …

What’s being presented at the AUA in May: Part III

In the “Outstanding Posters” sessions at the annual meeting of the American Urological Association meeting upcoming in Orlando, there are several posters that deal specifically with prostate cancer-related issues. … READ MORE …

“Best care” doesn’t equate to better outcomes! That’s not good!

A poster by Schroeck et al. — to be presented on May 20 at the upcoming annual meeting of the American Urological Association (AUA) — presents the latest set of data suggesting that “best care” does not lead to appropriate outcomes quality for men receiving standard forms of treatment for localized prostate cancer. … READ MORE …

Circumcision and risk for prostate cancer: an unresolved debate

For more than 70 years there has been an ongoing if sporadic debate about whether circumcision (in infancy or later in life) has any impact on risk for prostate cancer … or not. … READ MORE …

Another potential genomic test for prostate cancer aggression

In a presentation given last Saturday at the annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Vienna, a Canadian research team introduced yet another potential test that may be helpful in differentiating between patients at relatively high or low risk for metastasis, based on biopsy tissue. … READ MORE …

Early data on the accuracy and potential of the 4Kscore test

The late-breaking abstract for the results of a US-based study of the accuracy of the new 4Kscore Test™ has just been made available on  line. … READ MORE …

New Phase I/II trial of InSightec’s MRI-guided focal ultrasound therapy

According to a media release issued yesterday by the City of Hope medical center in Los Angeles, they have become the first center in the USA to treat a patient with focused, MRI-guided, ultrasound technology using the InSightec system. … READ MORE …

Gleason score and metastatic prostate cancer; risk for 4-year mortality

It is difficult to accurately interpret a set of data just published that was designed to assess the relationship between 4-year survival and Gleason score at diagnosis in men initially diagnosed with metastatic prostate cancer. … READ MORE …

OPKO launches 4Kscore Test™ for risk of prostate cancer; data still to come

According to a media release on the OPKO corporate web site, the company is now starting to carry out its previously discussed 4Kscore test for urologists and their patients here in the USA through its CLIA-accredited laboratory in Nashville, Tennessee. … READ MORE …

Just how good is multiparametric, 3-T MRI at finding, staging localized disease?

It is clear that modern magnetic resonance imaging is getting closer to being able to make a major difference to the way that we diagnose (and potentially manage) localized prostate cancer … always assuming we can afford the costs involved (at least here in the USA). … READ MORE …

What to make of a PCA3 score of ≥ 100

Some studies (e.g., this one by Roobol et al.) have previously indicated that not all men with very high prostate cancer antigen 3 (PCA3) scores are necessarily found to have prostate cancer on biopsy or re-biopsy. … READ MORE …

Focal therapy for organ-confined prostate cancer: an expert overview

For those who are interested in the current state of focal therapy in the management of localized, organ-confined prostate cancer, there is a nice audio overview by Dr. James Eastham of the Memorial Sloan-Kettering Cancer Center on the UroToday web site. … READ MORE …

Let’s compare the media hype to the actual data (about MR-guided biopsy)

According to an article online in The Australian today, “Men won’t need to have numerous painful needles in their rectum to find out if they have prostate cancer anymore”. … READ MORE …

“Observation” in the management of low-risk prostate cancer

In an article in Recent Results in Cancer Research, Wilt argues (yet again)  that “observation” (i.e., something less than active surveillance and perhaps more like “watchful waiting”) is an entirely appropriate way to manage selected men with low-risk prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,074 other followers